These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 12926051)

  • 1. Dominance of CD4+ alpha/beta T-cells and inferior role of innate immune reaction in liver metastases.
    Kasper HU; Drebber U; Zur Hausen A; Stippel D; Dienes HP; Dries V
    Anticancer Res; 2003; 23(4):3175-81. PubMed ID: 12926051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
    Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
    APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
    Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
    Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
    Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
    Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
    Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.
    Chin Y; Janseens J; Vandepitte J; Vandenbrande J; Opdebeek L; Raus J
    Anticancer Res; 1992; 12(5):1463-6. PubMed ID: 1332579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
    Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
    Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.
    Bricard G; Cesson V; Devevre E; Bouzourene H; Barbey C; Rufer N; Im JS; Alves PM; Martinet O; Halkic N; Cerottini JC; Romero P; Porcelli SA; Macdonald HR; Speiser DE
    J Immunol; 2009 Apr; 182(8):5140-51. PubMed ID: 19342695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
    Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
    Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors.
    Miescher S; Stoeck M; Qiao L; Barras C; Barrelet L; von Fliedner V
    Cancer Res; 1988 Dec; 48(24 Pt 1):6992-8. PubMed ID: 3263897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunologically-competent cells in liver infiltrating lymphocytes in patients with chronic severe hepatitis B].
    Zou ZS; Xu DP; Li BS; Huang L; Fu JL; Zhang Z; Jin L; Liu QF; Zhang H; Xin SJ; Wang FS
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2416-9. PubMed ID: 18036321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?
    van den Engel NK; Winter H; Rüttinger D; Shau I; Schiller M; Mayer B; Moudgil T; Meimarakis G; Stolte M; Jauch KW; Fox BA; Hatz RA
    Clin Immunol; 2006 Sep; 120(3):285-96. PubMed ID: 16765089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
    Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
    Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of colorectal cancer liver metastases: the immune/inflammatory infiltrate.
    Giuşcă SE; Zugun FE; Târcoveanu E; Carasevici E; Amălinei C; Căruntu ID
    Rom J Morphol Embryol; 2010; 51(1):73-9. PubMed ID: 20191123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma.
    Ryschich E; Nötzel T; Hinz U; Autschbach F; Ferguson J; Simon I; Weitz J; Fröhlich B; Klar E; Büchler MW; Schmidt J
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):498-504. PubMed ID: 15701833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
    Cózar JM; Canton J; Tallada M; Concha A; Cabrera T; Garrido F; Ruiz-Cabello Osuna F
    Cancer Immunol Immunother; 2005 Sep; 54(9):858-66. PubMed ID: 15887015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
    Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
    Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.